EDNRB and pulmonary arterial hypertension: In a dog model for PAH, ETBR antagonist RES-701-1 was found to increase pulmonary arterial pressure whereas sarafotoxin S6c, an ETBR agonist, decreased pulmonary arterial resistance [39].